Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Regnery

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Radiation Oncology (London, England)|June 8, 2023
Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trialSebastian Regnery, Chiara de Colle, Chukwuka Eze, et al.
Radiation Oncology (London, England)|May 4, 2023
Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trialSebastian Regnery, Chiara de Colle, Chukwuka Eze, et al.
Radiation Oncology (London, England)|April 18, 2021
3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trialThomas Held, Christopher Herpel, Franz Sebastian Schwindling, et al.
Oncotarget|July 10, 2018
Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patientsSebastian Regnery, Sebastian Adeberg, Constantin Dreher, et al.
Frontiers in Oncology|January 30, 2023
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodesTanja Eichkorn, Jonathan W Lischalk, Cedric Stüwe, et al.
Neuro-Oncology|November 14, 2025
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastomaThomas Zeyen, Inga Krause, Andreas Decker, et al.
Clinical and Translational Radiation Oncology|March 24, 2025
Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases - Which patients do really benefit from an MR-linac?Philipp Hoegen-Saßmannshausen, C Katharina Renkamp, Hoi Hin Lau, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 28, 2026
Assessment of multimodal CEST, perfusion and diffusion MRI for predicting clinical outcome of patients with diffuse glioma following surgery at baseline before radiotherapyNikolaus von Knebel Doeberitz, Petr Menshchikov, Florian Kroh, et al.
Frontiers in Psychology|January 3, 2022
Screening and Psycho-Oncological Support for Patients With Head and Neck Cancer and Brain Malignancies Before Radiotherapy With Mask Fixation: Results of a Feasibility StudySebastian Adeberg, Christina Sauer, Lena Lambert, et al.
International Journal of Cancer|August 30, 2024
Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapyFlorian Janke, Florian Stritzke, Katharina Dvornikovich, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Radiation Oncology (London, England)|June 8, 2023
Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trialSebastian Regnery, Chiara de Colle, Chukwuka Eze, et al.
Radiation Oncology (London, England)|May 4, 2023
Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trialSebastian Regnery, Chiara de Colle, Chukwuka Eze, et al.
Radiation Oncology (London, England)|April 18, 2021
3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trialThomas Held, Christopher Herpel, Franz Sebastian Schwindling, et al.
Oncotarget|July 10, 2018
Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patientsSebastian Regnery, Sebastian Adeberg, Constantin Dreher, et al.
Frontiers in Oncology|January 30, 2023
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodesTanja Eichkorn, Jonathan W Lischalk, Cedric Stüwe, et al.
Neuro-Oncology|November 14, 2025
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastomaThomas Zeyen, Inga Krause, Andreas Decker, et al.
Clinical and Translational Radiation Oncology|March 24, 2025
Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases - Which patients do really benefit from an MR-linac?Philipp Hoegen-Saßmannshausen, C Katharina Renkamp, Hoi Hin Lau, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 28, 2026
Assessment of multimodal CEST, perfusion and diffusion MRI for predicting clinical outcome of patients with diffuse glioma following surgery at baseline before radiotherapyNikolaus von Knebel Doeberitz, Petr Menshchikov, Florian Kroh, et al.
Frontiers in Psychology|January 3, 2022
Screening and Psycho-Oncological Support for Patients With Head and Neck Cancer and Brain Malignancies Before Radiotherapy With Mask Fixation: Results of a Feasibility StudySebastian Adeberg, Christina Sauer, Lena Lambert, et al.
International Journal of Cancer|August 30, 2024
Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapyFlorian Janke, Florian Stritzke, Katharina Dvornikovich, et al.
Pageof 8